Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T06:33:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The website has added new content, while the FDA Safety Alerts and Recalls section has been removed.
    Difference
    0.1%
    Check dated 2024-08-28T03:39:25.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-08-14T01:21:10.000Z thumbnail image
  5. Check
    30 days ago
    No Change Detected
  6. Check
    45 days ago
    Change Detected
    Summary
    The study has expanded to include 187 locations, and the website has been updated to version 2.10.0, replacing the previous version 2.9.7.
    Difference
    0.2%
    Check dated 2024-07-22T14:57:21.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T10:02:44.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-07-02T16:17:14.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.